Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment options.Axalbion has synthesized and examined new TRPM8 agonists, identifying its lead candidate AX-8.Our molecule AX-8 have a rapid onset of action and offer innovative topical treatment opportunities by normalizing abnormal cough ...
Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment options.Axalbion has synthesized and examined new TRPM8 agonists, identifying its lead candidate AX-8.Our molecule AX-8 have a rapid onset of action and offer innovative topical treatment opportunities by normalizing abnormal cough and lacrimation reflexes and by decreasing sensory discomfort.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.